Compare IVA & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVA | NPK |
|---|---|---|
| Founded | 2011 | 1905 |
| Country | France | United States |
| Employees | N/A | 1126 |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.0M | 722.3M |
| IPO Year | 2020 | N/A |
| Metric | IVA | NPK |
|---|---|---|
| Price | $4.45 | $103.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.14 | N/A |
| AVG Volume (30 Days) | ★ 233.5K | 55.2K |
| Earning Date | 09-29-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | N/A | ★ 14.20 |
| EPS | N/A | ★ 5.43 |
| Revenue | $19,929,536.00 | ★ $474,243,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.59 |
| Revenue Growth | N/A | ★ 34.75 |
| 52 Week Low | $2.11 | $77.63 |
| 52 Week High | $7.98 | $120.49 |
| Indicator | IVA | NPK |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 59.18 |
| Support Level | $4.05 | $91.28 |
| Resistance Level | $4.34 | $104.20 |
| Average True Range (ATR) | 0.23 | 2.96 |
| MACD | 0.06 | 1.56 |
| Stochastic Oscillator | 83.33 | 90.63 |
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.